Skip to main content
. 2021 Mar 15;13(6):1304. doi: 10.3390/cancers13061304

Figure 5.

Figure 5

Second-line treatment options for fit patients with metastatic or unresectable gastric or gastroesophageal junction adenocarcinoma. MSI, microsatellite instability.